Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 4
2004 8
2005 19
2006 12
2007 14
2008 9
2009 12
2010 13
2011 18
2012 26
2013 44
2014 29
2015 24
2016 60
2017 36
2018 39
2019 39
2020 51
2021 34
2022 39
2023 48
2024 38
2025 31

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

568 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean alaide, chieffo[au] (1 results)?
Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research Consortium.
Fezzi S, Scheller B, Cortese B, Alfonso F, Jeger R, Colombo A, Joner M, Shin ES, Kleber FX, Latib A, Rissanen TT, Eccleshall S, Ribichini F, Tao L, Koo BK, Chieffo A, Ge J, Granada JF, Stoll HP, Spaulding C, Cavalcante R, Abizaid A, Muramatsu T, Boudoulas KD, Waksman R, Mehran R, Cutlip DE, Krucoff MW, Stone GW, Garg S, Onuma Y, Serruys PW. Fezzi S, et al. Among authors: chieffo a. Eur Heart J. 2025 Jul 7;46(26):2498-2519. doi: 10.1093/eurheartj/ehaf029. Eur Heart J. 2025. PMID: 40270117 Free PMC article.
Sex-specific disparities in clinical characteristics and outcomes of catheter-directed treatments for acute pulmonary embolism.
Russo F, Morosato M, Sacco A, Iannaccone M, Colombo C, Chizzola G, Boccuzzi GG, Adamo M, Capsoni N, Bossi IE, Cianfanelli L, Solcia M, Fumarola F, Savio D, Bellini B, Ajello S, Galli M, Oliva F, Chieffo A, Montorfano M. Russo F, et al. Among authors: chieffo a. Int J Cardiol. 2025 Jun 23;438:133550. doi: 10.1016/j.ijcard.2025.133550. Online ahead of print. Int J Cardiol. 2025. PMID: 40562312
Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on Thrombosis.
Paradies V, Masiero G, Rubboli A, Van Beusekom HMM, Costa F, Capranzano P, Degrauwe S, Gorog DA, Jorge CM, Buchanan GL, Alasnag M, Trabattoni D, Fraccaro C, Sibbing D, Dudek D, Vilahur G, Chieffo A, Mehran R, Capodanno D, Barbato E, Siller-Matula JM. Paradies V, et al. Among authors: chieffo a. EuroIntervention. 2025 Jun 16;21(12):e655-e667. doi: 10.4244/EIJ-D-24-00876. EuroIntervention. 2025. PMID: 40388110 Free article.
Transcatheter vs. surgical aortic valve replacement in women: the RHEIA trial.
Tchetche D, Pibarot P, Bax JJ, Bonaros N, Windecker S, Dumonteil N, Nietlispach F, Messika-Zeitoun D, Pocock SJ, Berthoumieu P, Swaans MJ, Timmers L, Rudolph TK, Bleiziffer S, Leroux L, Modine T, van der Kley F, Auffret V, Tomasi J, Stastny L, Hengstenberg C, Andreas M, Leclercq F, Gandet T, Mascherbauer J, Trescher K, Prendergast B, Vasa-Nicotera M, Chieffo A, Mares J, Wesselink W, Rakova R, Kurucova J, Bramlage P, Eltchaninoff H. Tchetche D, et al. Among authors: chieffo a. Eur Heart J. 2025 Jun 9;46(22):2079-2088. doi: 10.1093/eurheartj/ehaf133. Eur Heart J. 2025. PMID: 40171878 Clinical Trial.
SCAI/EAPCI/ACVC Expert Consensus Statement on Cardiogenic Shock in Women: This statement was endorsed by the Heart Failure Society of America (HFSA).
Baron SJ, Chou JC, Shah T, Vest AR, Abbott JD, Alasnag M, Aurigemma C, Barbato E, Bellumkonda L, Bortnick AE, Chieffo A, Geuns RV, Grines CL, Halvorsen S, Hassager C, Kapur NK, Naidu SS, Ng VG, Saw J, Lansky AJ. Baron SJ, et al. Among authors: chieffo a. J Soc Cardiovasc Angiogr Interv. 2025 May 20;4(6):102150. doi: 10.1016/j.jscai.2024.102150. eCollection 2025 Jun. J Soc Cardiovasc Angiogr Interv. 2025. PMID: 40630254 Free PMC article.
Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on Thrombosis.
Paradies V, Masiero G, Rubboli A, Van Beusekom HMM, Costa F, Capranzano P, Degrauwe S, Gorog DA, Jorge CM, Buchanan GL, Alasnag M, Trabattoni D, Fraccaro C, Sibbing D, Dudek D, Vilahur G, Chieffo A, Mehran R, Capodanno D, Barbato E, Siller-Matula JM. Paradies V, et al. Among authors: chieffo a. Eur Heart J. 2025 May 20:ehaf352. doi: 10.1093/eurheartj/ehaf352. Online ahead of print. Eur Heart J. 2025. PMID: 40390370
SCAI/EAPCI/ACVC Expert Consensus Statement on Cardiogenic Shock in Women.
Baron SJ, Chou JC, Shah T, Vest AR ¶, Abbott JD, Alasnag M †, Aurigemma C †, Barbato E †, Bellumkonda L, Bortnick AE ‡, Chieffo A †, van Geuns RJ †, Grines CL, Halvorsen S §, Hassager C §, Kapur NK, Naidu SS, Ng VG, Saw J, Lansky AJ. Baron SJ, et al. Among authors: chieffo a. EuroIntervention. 2025 May 20:EIJ-D-24-01126. doi: 10.4244/EIJ-D-24-01126. Online ahead of print. EuroIntervention. 2025. PMID: 40387531 Free article.
Long-term structural valve deterioration after TAVI: insights from the EORP ESC Valve Durability TAVI Registry.
Giannini C, Capodanno D, Toth GG, Windecker S, Schüpke S, Blackman DJ, Noble S, Eltchaninoff H, Fiorina C, Chieffo A, Bartorelli AL, Schmidt A, De Backer O, Gilard M, Curtis E, L'Official G, Donal E, Laroche C, Prendergast B, Petronio AS, The European Valve Durability Tavi Registry Investigators OB. Giannini C, et al. Among authors: chieffo a. EuroIntervention. 2025 May 16;21(10):537-549. doi: 10.4244/EIJ-D-24-00662. EuroIntervention. 2025. PMID: 40375761 Free article.
Percutaneous Coronary Intervention for Left Main Disease in High Bleeding Risk: Outcomes from a Subanalysis of the Delta 2 Registry.
Botti G, Federico F, Meliga E, Daemen J, D'Ascenzo F, Capodanno D, Dumonteil N, Tchetche D, Van Mieghem NM, Nakamura S, Garot P, Erglis A, Vella C, Tamburino C, Morice MC, Mehran R, Montorfano M, Chieffo A. Botti G, et al. Among authors: chieffo a. J Cardiovasc Dev Dis. 2025 May 11;12(5):179. doi: 10.3390/jcdd12050179. J Cardiovasc Dev Dis. 2025. PMID: 40422950 Free PMC article.
568 results